Found: 9
Select item for more details and to access through your institution.
Rising Drug Costs Drives the Growth of Pharmacy Benefit Managers Exclusion Lists: Are Exclusion Decisions Value-Based?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Trial watch: Personalized medicines in late-stage development.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 324, doi. 10.1038/nrd4325
- By:
- Publication type:
- Article
Market watch: Industry perspectives on personalized medicine.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 3, p. 178, doi. 10.1038/nrd3677
- By:
- Publication type:
- Article
Orphan products?pain relief for clinical development headaches.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 8, p. 780, doi. 10.1038/nbt0802-780
- By:
- Publication type:
- Article
FOREWORD.
- Published in:
- PharmacoEconomics, 2006, p. 1, doi. 10.2165/00019053-200624002-00001
- By:
- Publication type:
- Article
Foreword.
- Published in:
- PharmacoEconomics, 2004, v. 22, p. 5, doi. 10.2165/00019053-200422001-00001
- By:
- Publication type:
- Article
Are Regulation and Innovation Priorities Serving Public Health Needs?
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00144
- By:
- Publication type:
- Article
Translational Medicine: An Engine of Change for Bringing New Technology to Community Health.
- Published in:
- Science Translational Medicine, 2009, v. 1, n. 5, p. 1, doi. 10.1126/scitranslmed.3000222
- By:
- Publication type:
- Article
Down the Critical Path: Who Should Lead?
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 8, p. 56
- By:
- Publication type:
- Article